Ownership history in ORBIMED ADVISORS LLC · 23 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in PASSAGE BIO INC (PASG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 59,046 | -5,996,254 | -99.0% | 0.01% | $474K | $8.03 |
| 2025 Q2 | REDUCED | 6,055,300 | -979,326 | -13.9% | 0.06% | $2.4M | $8.00 |
| 2025 Q1 | REDUCED | 7,034,626 | -370,243 | -5.0% | 0.06% | $2.5M | $7.06 |
| 2024 Q4 | REDUCED | 7,404,869 | -2,418,007 | -24.6% | 0.09% | $4.2M | $11.34 |
| 2024 Q3 | REDUCED | 9,822,876 | -301,700 | -3.0% | 0.12% | $6.9M | $14.00 |
| 2024 Q2 | UNCHANGED | 10,124,576 | — | 0% | 0.16% | $8.0M | $15.88 |
| 2024 Q1 | UNCHANGED | 10,124,576 | — | 0% | 0.25% | $13.7M | $27.00 |
| 2023 Q4 | UNCHANGED | 10,124,576 | — | 0% | 0.20% | $10.2M | $20.20 |
| 2023 Q3 | UNCHANGED | 10,124,576 | — | 0% | 0.14% | $6.7M | $13.16 |
| 2023 Q2 | ADDED | 10,124,576 | +1,192,577 | +13.4% | 0.17% | $9.5M | $18.82 |
As of 2025 Q4 — sorted by position size